Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
International Journal of Neonatal Screening|October 29, 2020
Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An UpdateBarbara K Burton, Rachel Hickey, Lauren HitchinsAnalytical Biochemistry|August 22, 2018
Peptide ligand-based ELISA reagents for antibody detectionEwa Heyduk, Rachel Hickey, Nicola Pozzi, et al.American Journal of Medical Genetics. Part A|April 12, 2026
The Critical Role of Fractionated Urine Glycosaminoglycans in the Evaluation of Mucopolysaccharidosis Type II in Four Unrelated FamiliesCarly A Rasmussen, Monika Izdebski, Allison Paltzer, et al.International Journal of Neonatal Screening|January 25, 2022
Newborn Screening for X-Linked Adrenoleukodystrophy: The Initial Illinois ExperienceBarbara K Burton, Rachel Hickey, Lauren Hitchins, et al.Molecular Genetics and Metabolism|November 24, 2023
Treatment-naive and post-treatment glucosylsphingosine (lyso-GL1) levels in a cohort of pediatric patients with Gaucher diseaseCarly A Rasmussen, Allegra Quadri, Erika Vucko, et al.International Journal of Neonatal Screening|October 19, 2020
Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 InfantsBarbara K Burton, Joel Charrow, George E Hoganson, et al.The Journal of Pediatrics|September 4, 2019
Population-Based Newborn Screening for Mucopolysaccharidosis Type II in Illinois: The First Year ExperienceBarbara K Burton, George E Hoganson, Julie Fleischer, et al.Pageof 1